PMC:7172841 / 840-973 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":28,"end":34},"obj":"Body_part"},{"id":"T10","span":{"begin":45,"end":48},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"fluenza. SARS-CoV-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T13","span":{"begin":9,"end":17},"obj":"Disease"},{"id":"T14","span":{"begin":9,"end":13},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"fluenza. SARS-CoV-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":28,"end":34},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"fluenza. SARS-CoV-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":49,"end":51},"obj":"Chemical"},{"id":"T6","span":{"begin":103,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A7","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"fluenza. SARS-CoV-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T29","span":{"begin":9,"end":19},"obj":"SP_7"},{"id":"T30","span":{"begin":28,"end":34},"obj":"UBERON:0001969"},{"id":"T31","span":{"begin":45,"end":48},"obj":"PR:000029150"},{"id":"T32","span":{"begin":52,"end":62},"obj":"GO:0010467"},{"id":"T33","span":{"begin":103,"end":107},"obj":"PR:000001393"},{"id":"T34","span":{"begin":116,"end":127},"obj":"DG_35"},{"id":"T85947","span":{"begin":9,"end":19},"obj":"SP_7"},{"id":"T29939","span":{"begin":28,"end":34},"obj":"UBERON:0001969"},{"id":"T8998","span":{"begin":45,"end":48},"obj":"PR:000029150"},{"id":"T62491","span":{"begin":52,"end":62},"obj":"GO:0010467"},{"id":"T78149","span":{"begin":103,"end":107},"obj":"PR:000001393"},{"id":"T18501","span":{"begin":116,"end":127},"obj":"DG_35"}],"text":"fluenza. SARS-CoV-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-"}

{"project":"LitCovid-PubTator","denotations":[{"id":"42","span":{"begin":103,"end":107},"obj":"Gene"},{"id":"46","span":{"begin":9,"end":19},"obj":"Species"},{"id":"47","span":{"begin":20,"end":27},"obj":"Species"},{"id":"51","span":{"begin":116,"end":127},"obj":"Chemical"}],"attributes":[{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Gene:3569"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"Tax:2697049"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:9606"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"fluenza. SARS-CoV-2 patient plasma inhibited HLA-DR expression, and this was partially restored by the IL-6 blocker Tocilizumab; off-"}